On April 5, 2022, NewGLAB Pharma CO.,LTD closed the transaction.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
1,383 KRW | -27.44% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 47.7M | |
+27.99% | 2.05B | |
-18.13% | 1.1B | |
+15.53% | 821M | |
+63.73% | 820M | |
-11.30% | 766M | |
+47.35% | 671M | |
-27.86% | 364M | |
-15.01% | 279M | |
+97.60% | 245M |
- Stock Market
- Equities
- A214870 Stock
- News NewGLAB Pharma CO.,LTD
- NewGLAB Pharma CO.,LTD announced that it has received KRW 25 billion in funding from DB Financial Investment Co.,Ltd., Investment Arm